Clinical Trial Update: Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating platelet reactivity in relation to ticagrelor dose after transcatheter aortic valve implantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Aortic Stenosis

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Andres Iñiguez Romo | Conditions: Symptomatic Aortic Stenosis | Phase 4 | Status: COMPLETED